NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its third-quarter revenues increased nearly 2 percent, but were up 5 percent on a currency-neutral basis.

The Franklin Lakes, NJ-based medical devices, diagnostics, and research products firm generated total revenues of $1.98 billion for the quarter ended June 30, compared to $1.95 billion for the third quarter of 2011. It missed analysts' consensus estimate of $2.02 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.